Lysosomal storage disorder 4 + 1 multiplex assay for newborn screening using tandem mass spectrometry: Application to a small-scale population study for five lysosomal storage disorders

详细信息	查看全文 | 推荐本文 |

• 作者：Joseph J. Orsini^a ; ^{jjo01@health.state.ny.us} ; Monica M. Martin^a ; Amanda L. Showers^a ; Olaf A. Bodamer^b ; X. Kate Zhang^c ; Michael H. Gelb^d ; ^e ; Michele Caggana^a
• 关键词：LSD ; lysosomal storage disorder ; DBS ; dried blood spot ; DMA ; daily mean activity ; ESI-MS/MS ; electrospray ionization-tandem mass spectrometry ; ABG ; acid 尾-glucocerebrosidase ; ASM ; acid sphingomyelinase ; GAA ; acid 伪-glucosidase ; GALC ; galactocerebrosidas
• 刊名：Clinica Chimica Acta
• 出版年：2012
• 期刊代码：54_00098981
• 类别：med
• 出版时间：16 August, 2012
• 卷：413
• 期：15-16
• 页码：1270-1273
• 文件大小：158 K

摘要

Background

We sought to modify a previously published tandem mass spectrometry method of screening for 5 lysosomal storage disorders (LSDs) in order to make it better suited for high-throughput newborn screening.

Methods

Two 3-mm dried blood spot (DBS) punches were incubated, each with a different assay solution. The quadruplex solution was used for screening for Gaucher, Pompe, Krabbe and Fabry diseases, while a separate solution was used for Niemann-Pick A/B disease.

Results

The mean activities of acid-尾-glucocerebrosidase (ABG), acid sphingomyelinase (ASM), acid glucosidase (GAA), galactocerebroside-尾-galactosidase (GALC) and acid-galactosidase A (GLA) were measured on 5055 unidentified newborns. The mean activities (compared with their disease controls) were, 15.1 (0.35), 22.2 (1.34), 16.8 (0.51), 3.61 (0.23), and 20.7 (1.43) (渭mol/L/h), respectively. The number of specimens that fell below our retest level cutoff of < 20%daily mean activity (DMA) for each analyte is: ABG (6), ASM (0), GAA (5), GALC (17), and GLA (2).

Conclusions

This method provides a simplified and reliable assay for screening for five LSDs with clear distinction between activities from normal and disease samples. Advantages of this new method include significant decreases in processing time and the number of required assay solutions and overall decreased complexity.